| scholarly article | Q13442814 |
| P2093 | author name string | Michael Abel | |
| James D Oliver | |||
| Nina Shah | |||
| Matthew Lewin | |||
| Ryan Burkhart | |||
| P2860 | cites work | Systemic lupus erythematosus associated with ANCA-associated vasculitis: an overlapping syndrome? | Q33396447 |
| Efficacy of remission-induction regimens for ANCA-associated vasculitis | Q34037683 | ||
| A case of myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA)-associated glomerulonephritis and concurrent membranous nephropathy | Q34640276 | ||
| Plasma exchange for renal vasculitis and idiopathic rapidly progressive glomerulonephritis: a meta-analysis | Q34708735 | ||
| Rituximab versus cyclophosphamide for ANCA-associated vasculitis | Q35109118 | ||
| Membranous glomerulopathy with superimposed pauci-immune necrotizing crescentic glomerulonephritis | Q35453116 | ||
| Antineutrophil cytoplasmic autoantibodies in systemic lupus erythematosus | Q35545589 | ||
| Necrotizing and crescentic lupus nephritis with antineutrophil cytoplasmic antibody seropositivity | Q36662094 | ||
| Membranous glomerulonephritis with ANCA-associated necrotizing and crescentic glomerulonephritis. | Q37087861 | ||
| KDOQI US commentary on the 2012 KDIGO clinical practice guideline for glomerulonephritis | Q38122875 | ||
| Crescentic transformation in primary membranous glomerulonephritis | Q38649561 | ||
| Membranous lupus nephritis with antineutrophil cytoplasmic antibody-associated segmental necrotizing and crescentic glomerulonephritis | Q41323438 | ||
| Should rituximab be used to prevent relapse in patients with ANCA-associated vasculitis? | Q42380186 | ||
| Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis | Q42963758 | ||
| Clinicopathological characteristics and outcomes of patients with crescentic lupus nephritis | Q45239422 | ||
| Acute renal failure in membranous glomerulonephropathy: a result of superimposed crescentic glomerulonephritis | Q71373659 | ||
| Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease | Q73366591 | ||
| Membranous and crescentic glomerulonephritis in a patient with anti-nuclear and anti-neutrophil cytoplasmic antibodies | Q79226771 | ||
| Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis | Q80507400 | ||
| SLE and rapidly progressive glomerulonephritis | Q81699418 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | glomerulonephritis | Q605006 |
| lupus nephritis | Q1621830 | ||
| Pauci-immune | Q7148839 | ||
| crescentic glomerulonephritis | Q18554448 | ||
| P304 | page(s) | 120762 | |
| P577 | publication date | 2015-10-08 | |
| P1433 | published in | Case reports in nephrology | Q27725325 |
| P1476 | title | Pauci-Immune Necrotizing and Crescentic Glomerulonephritis with Membranous Lupus Nephritis, Fifteen Years after Initial Diagnosis of Secondary Membranous Nephropathy | |
| P478 | volume | 2015 |
| Q90730625 | ANCA-Associated Necrotizing Glomerulonephritis Overlapping with Mesangial Proliferative Lupus Nephritis Refractory to Plasmapheresis, Steroid Pulse Therapy, and a Combination of Mycophenolate Mofetil and Rituximab | cites work | P2860 |
Search more.